Karah Parschauer

Insider Reports History

Location
Novato, CA
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Karah Parschauer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karah Parschauer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Common Stock 73,271 $2,283,857 $31.17 12 Sep 2025 Direct
Evolus, Inc. Director Common Stock 77,742 $390,264 $5.02 17 Feb 2026 Direct
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 107,400 29 May 2025 Direct
Anebulo Pharmaceuticals, Inc. Director Stock Option (right to buy) 30,425 21 Apr 2022 Direct
Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Stock Option (Right to Buy) 26,074 01 Mar 2025 Direct
Arcturus Therapeutics Holdings Inc. Director Stock Option (right to buy) 15,000 18 Jun 2021 Direct
Evolus, Inc. Director Stock Option (Right to Buy) 11,146 07 Mar 2025 Direct

Insider Reports Filed by Karah Parschauer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EOLS Evolus, Inc. 17 Feb 2026 1 $0 4 Director 19 Feb 2026, 20:57
RARE Ultragenyx Pharmaceutical Inc. 12 Sep 2025 1 -$76,366 4 EVP and Chief Legal Officer 12 Sep 2025, 16:11
TNYA Tenaya Therapeutics, Inc. 29 May 2025 1 $0 4 Director 30 May 2025, 18:48
EOLS Evolus, Inc. 12 Mar 2025 1 -$167,465 4 Director 14 Mar 2025, 17:59
EOLS Evolus, Inc. 07 Mar 2025 2 $0 4 Director 11 Mar 2025, 18:53
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2025 2 -$540,817 4 EVP and Chief Legal Officer 04 Mar 2025, 20:18
RARE Ultragenyx Pharmaceutical Inc. 27 Feb 2025 4 -$128,224 4 EVP and Chief Legal Officer 03 Mar 2025, 13:58
TNYA Tenaya Therapeutics, Inc. 18 Oct 2024 1 $0 4 Director 21 Oct 2024, 20:39
RARE Ultragenyx Pharmaceutical Inc. 12 Jun 2024 1 -$441,270 4 EVP and Chief Legal Officer 12 Jun 2024, 19:47
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2024 4 -$201,923 4 EVP and Chief Legal Officer 05 Mar 2024, 20:22
EOLS Evolus, Inc. 07 Feb 2024 2 $0 4 Director 09 Feb 2024, 18:37
EOLS Evolus, Inc. 30 Jan 2024 1 -$156,733 4 Director 02 Feb 2024, 16:57
TNYA Tenaya Therapeutics, Inc. 09 Jun 2023 1 $0 4 Director 12 Jun 2023, 20:24
RARE Ultragenyx Pharmaceutical Inc. 04 May 2023 1 -$197,010 4 EVP and Chief Legal Officer 05 May 2023, 14:16
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2023 4 -$143,035 4 EVP and Chief Legal Officer 03 Mar 2023, 18:59
EOLS Evolus, Inc. 27 Jan 2023 2 $0 4 Director 31 Jan 2023, 19:41
TNYA Tenaya Therapeutics, Inc. 08 Sep 2022 1 $0 4 Director 09 Sep 2022, 19:25
ANEB Anebulo Pharmaceuticals, Inc. 21 Apr 2022 1 $0 4 Director 03 Oct 2022, 19:56
RARE Ultragenyx Pharmaceutical Inc. 07 Mar 2022 1 -$323,563 4 EVP and Chief Legal Officer 08 Mar 2022, 11:25
RARE Ultragenyx Pharmaceutical Inc. 01 Mar 2022 3 -$192,265 4 EVP and Chief Legal Officer 03 Mar 2022, 17:08
EOLS Evolus, Inc. 24 Jan 2022 2 $0 4 Director 26 Jan 2022, 20:01
TNYA Tenaya Therapeutics, Inc. 22 Dec 2021 1 $0 4 Director 23 Dec 2021, 16:58
TNYA Tenaya Therapeutics, Inc. 22 Dec 2021 0 $0 3 Director 23 Dec 2021, 16:55
RARE Ultragenyx Pharmaceutical Inc. 14 Oct 2021 1 -$25,153 4 EVP and General Counsel 18 Oct 2021, 18:46
RARE Ultragenyx Pharmaceutical Inc. 08 Sep 2021 3 -$338,556 4 EVP and General Counsel 09 Sep 2021, 18:22
ARCT Arcturus Therapeutics Holdings Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 18:33
RARE Ultragenyx Pharmaceutical Inc. 10 Jun 2021 1 -$132,900 4 EVP and General Counsel 11 Jun 2021, 21:08
RARE Ultragenyx Pharmaceutical Inc. 06 May 2021 1 -$35,579 4 EVP and General Counsel 10 May 2021, 18:13